176 related articles for article (PubMed ID: 27604718)
21. Clinical and model research of neurotrauma.
Büki A; Kövesdi E; Pál J; Czeiter E
Methods Mol Biol; 2009; 566():41-55. PubMed ID: 20058163
[TBL] [Abstract][Full Text] [Related]
22. Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery.
Guingab-Cagmat JD; Cagmat EB; Hayes RL; Anagli J
Front Neurol; 2013; 4():61. PubMed ID: 23750150
[TBL] [Abstract][Full Text] [Related]
23. Proteomic identification of biomarkers of traumatic brain injury.
Wang KK; Ottens AK; Liu MC; Lewis SB; Meegan C; Oli MW; Tortella FC; Hayes RL
Expert Rev Proteomics; 2005 Aug; 2(4):603-14. PubMed ID: 16097892
[TBL] [Abstract][Full Text] [Related]
24. Novel neuroproteomic approaches to studying traumatic brain injury.
Ottens AK; Kobeissy FH; Fuller BF; Liu MC; Oli MW; Hayes RL; Wang KK
Prog Brain Res; 2007; 161():401-18. PubMed ID: 17618994
[TBL] [Abstract][Full Text] [Related]
25. Proteomic biomarkers for blast neurotrauma: targeting cerebral edema, inflammation, and neuronal death cascades.
Agoston DV; Gyorgy A; Eidelman O; Pollard HB
J Neurotrauma; 2009 Jun; 26(6):901-11. PubMed ID: 19397421
[TBL] [Abstract][Full Text] [Related]
26. Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Lista S; Zetterberg H; O'Bryant SE; Blennow K; Hampel H
Methods Mol Biol; 2017; 1598():101-115. PubMed ID: 28508359
[TBL] [Abstract][Full Text] [Related]
27. TMT-based proteomics analysis to screen potential biomarkers of acute-phase TBI in rats.
Wang H; Chen J; Gao C; Chen W; Chen G; Zhang M; Luo C; Wang T; Chen X; Tao L
Life Sci; 2021 Jan; 264():118631. PubMed ID: 33131748
[TBL] [Abstract][Full Text] [Related]
28. Use of biomarkers for diagnosis and management of traumatic brain injury patients.
Papa L; Robinson G; Oli M; Pineda J; Demery J; Brophy G; Robicsek SA; Gabrielli A; Robertson CS; Wang KK; Hayes RL
Expert Opin Med Diagn; 2008 Aug; 2(8):937-45. PubMed ID: 23495867
[TBL] [Abstract][Full Text] [Related]
29. Proteomics: in pursuit of effective traumatic brain injury therapeutics.
Lizhnyak PN; Ottens AK
Expert Rev Proteomics; 2015 Feb; 12(1):75-82. PubMed ID: 25603864
[TBL] [Abstract][Full Text] [Related]
30. Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury.
Kurowski BG; Treble-Barna A; Pitzer AJ; Wade SL; Martin LJ; Chima RS; Jegga A
J Neurotrauma; 2017 Jul; 34(14):2280-2290. PubMed ID: 28301983
[TBL] [Abstract][Full Text] [Related]
31. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
[TBL] [Abstract][Full Text] [Related]
32. Perspectives on molecular biomarkers of oxidative stress and antioxidant strategies in traumatic brain injury.
Mendes Arent A; de Souza LF; Walz R; Dafre AL
Biomed Res Int; 2014; 2014():723060. PubMed ID: 24689052
[TBL] [Abstract][Full Text] [Related]
33. Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.
Abou-El-Hassan H; Sukhon F; Assaf EJ; Bahmad H; Abou-Abbass H; Jourdi H; Kobeissy FH
Methods Mol Biol; 2017; 1598():65-99. PubMed ID: 28508358
[TBL] [Abstract][Full Text] [Related]
34. Neuroimaging and traumatic brain injury: State of the field and voids in translational knowledge.
Bruce ED; Konda S; Dean DD; Wang EW; Huang JH; Little DM
Mol Cell Neurosci; 2015 May; 66(Pt B):103-13. PubMed ID: 25827094
[TBL] [Abstract][Full Text] [Related]
35. Making the Case for Functional Proteomics.
Perkins RC
Methods Mol Biol; 2019; 1871():1-40. PubMed ID: 30276729
[TBL] [Abstract][Full Text] [Related]
36. Translation of neurological biomarkers to clinically relevant platforms.
Hayes RL; Robinson G; Muller U; Wang KK
Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
[TBL] [Abstract][Full Text] [Related]
37. Multiplexed Quantitative Proteomics Reveals Proteomic Alterations in Two Rodent Traumatic Brain Injury Models.
Park J; Lee SH; Shin D; Kim Y; Kim YS; Seong MY; Lee JJ; Seo HG; Cho WS; Ro YS; Kim Y; Oh BM
J Proteome Res; 2024 Jan; 23(1):249-263. PubMed ID: 38064581
[TBL] [Abstract][Full Text] [Related]
38. Brain injury and proteomics/peptidomics: is it relevant? an overview.
Schuhmann MU; Heine G; Skardelly M; Jaeger M; Selle H
Acta Neurochir Suppl; 2005; 95():465-70. PubMed ID: 16463902
[TBL] [Abstract][Full Text] [Related]
39. The role of biomarkers and MEG-based imaging markers in the diagnosis of post-traumatic stress disorder and blast-induced mild traumatic brain injury.
Huang M; Risling M; Baker DG
Psychoneuroendocrinology; 2016 Jan; 63():398-409. PubMed ID: 25769625
[TBL] [Abstract][Full Text] [Related]
40. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
